14th Annual Cardiometabolic Health Congress (CMHC)

14th Annual Cardiometabolic Health Congress (CMHC) is organized by Tarsus CNS and will be held from Oct 10 - 13, 2019 at Marriott Marquis Chicago, Chicago, Illinois, United States of America.

Target Audience:
The CMHC is designed for advanced level clinicians responsible for the prevention, diagnosis, and management of cardiometabolic risk including cardiologists, endocrinologists, diabetologists, lipidologists, pharmacists, primary care clinicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), and other allied health professionals.

Accreditation:
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 23.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 23.25 contact hour(s) (2.325 CEUs) of the Accreditation Council for Pharmacy Education.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 23.2 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.

Continuing Dietician Education
Postgraduate Institute for Medicine (CDR Provider #3631) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 23.5 Continuing Professional Education units (CPEUs) for completion of this activity.

MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 23.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Request For Credits
Learners may earn up to a maximum of 24.5 AMA/ACPE, 24.4 ANCC, or 25 CDR credit hours by attending all General Sessions and CME Satellite Symposia. Full credit information will be provided in the final conference guide.

Overview:
As the growing international public health crisis of cardiovascular disease continues to plague the globe, it is imperative for clinicians to equip themselves with hands-on therapeutic practices & protocols that can be directly applied to patients. With recent statistics indicating that over one-third of the population has at least one cardiometabolic risk factor?including dyslipidemia, CVD, hypertension, diabetes, and/or obesity?the Cardiometabolic Health Congress serves as the go-to forum for health practitioners to stay educated and clinically current.

Now in its 14th year, CMHC is the largest, US-based, multidisciplinary conference that is solely focused on the management of cardiometabolic risk, and the prevention of cardiovascular and metabolic disease. Through a thorough and comprehensive 3 ½ days planned and led by the country's top academic experts, researchers, and thought leaders, this event allows today's busy healthcare professionals a uniquely exclusive opportunity to learn, internalize, and integrate real-world solutions into their toolboxes: and ultimately, their clinical practices & patient care.

The 2019 CMHC will translate the latest cutting-edge medical research into practical, clinical strategies for preventing, delaying, diagnosing, treating, and managing cardiovascular and metabolic disorders. The goal is to provide the medical community with evidence-based interventions that they can apply immediately in clinical practice to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.

Session Topics Include:
• Cardiometabolic Technology Summit
• Prevention of Metabolic Syndrome
• Gut Microbiota: How does it affect Cardiometabolic Health?
• Role of Genetic Risk Scores for the Prevention of Cardiometabolic Disease
• SGLT2 Inhibitors and Renal Preservation
• Lifestyle Approaches to Weight Reduction - Challenges Before Us
• Biomarkers in CVD - Global CVD Risk Assessment

Educational Objectives:
• Discuss the interrelationships among cardiometabolic risk factors and their impact on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease.
• Interpret the latest evidence and guidelines for the prevention, screening, and treatment of the complex patient with cardiometabolic risk or cardiometabolic disease.
• Outline strategies aimed at timely screening and prevention of cardiometabolic disease, including biomarkers, imaging, genetic risk assessment, and lifestyle modifications.
• Develop individualized treatment regimens for patients with cardiometabolic disease based on the efficacy and safety of current and new pharmacotherapies, patient comorbidities and preferences to optimize outcomes.
• Summarize recent evidence for emerging therapies in order to stay current with the most recent updates in the cardiometabolic field.
• Employ strategies that promote patient-centered care, including patient communication and education, in order to optimize adherence to treatment regimens.
• Recognize the role of real-world evidence, data science, and technology in aiding and improving care for cardiometabolic diseases.

Workshops:
• ACC and ADA Unified Approach to CV Risk Reduction
Friday, October 11, 2019
10:20 am – 11:10 am

• Navigating Insulin Access and Cost
Friday, October 11, 2019
2:30 pm – 3:15 pm

• Navigating the Prior Authorization Process
Friday, October 11, 2019
4:10 pm – 5:00 pm

• Biomarkers in CVD – Global CVD Risk Assessment
Saturday, October 12, 2019
9:10 am – 9:50 am

• Statin Intolerance
Saturday, October 12, 2019
10:05 am – 10:45 am

• When Do You Use Ambulatory BP Monitoring?
Saturday, October 12, 2019
2:25 pm – 3:10 pm

• The Role of Potassium-Binding Agents in Optimizing HF Guidelines
Saturday, October 12, 2019
4:30 pm – 5:10 pm

• Progresses and Challenges in Obesity Pharmacotherapy
Sunday, October 13, 2019
10:25 am – 11:05 am

Additional details will be posted as soon as they are available.